Literature DB >> 10739414

Neurological signs and the heterogeneity of schizophrenia.

C Arango1, B Kirkpatrick, R W Buchanan.   

Abstract

OBJECTIVE: More than 20 studies of schizophrenia have found a three-factor model of symptom complexes or syndromes consisting of hallucinations/delusions, disorganization of thought and behavior, and negative symptoms. Several lines of evidence suggest that these syndromes relate to neurobiological differences. We examined the relationship of these three syndromes to neurological signs.
METHOD: The relationships among the subscales of the Neurological Evaluation Scale and hallucinations/delusions, disorganization, and the deficit syndrome were examined in 83 clinically stable outpatients with schizophrenia. Patients with the deficit syndrome have enduring, idiopathic (or primary) negative symptoms.
RESULTS: Each of the three syndromes had a distinctive pattern of relationships to neurological signs. Disorganization was significantly related to the total score on the Neurological Evaluation Scale, to sensory integration, and to the sequencing of complex motor acts. The deficit syndrome was significantly related to sensory integration only. Neither hallucinations/delusions nor a continuous measure of negative symptoms derived from the Brief Psychiatric Rating Scale (that measured both primary and secondary negative symptoms, as well as enduring and transient symptoms) was related to any of the Neurological Evaluation Scale subscales or total score. Drug treatment was not related to neurological impairment.
CONCLUSIONS: The results further support the neurobiological significance of the three clinical syndromes of schizophrenia. Ratings on a scale measuring negative symptoms appear to be less sensitive to neurobiological correlates than is the categorization of the presence or absence of the deficit syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739414     DOI: 10.1176/appi.ajp.157.4.560

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

2.  Progress in the study of negative symptoms.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

3.  Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit features.

Authors:  Hanan D Trotman; Brian Kirkpatrick; Michael T Compton
Journal:  Schizophr Res       Date:  2011-03       Impact factor: 4.939

4.  Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

Authors:  Faith Dickerson; Brian Kirkpatrick; John Boronow; Cassie Stallings; Andrea Origoni; Robert Yolken
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

5.  Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.

Authors:  Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2012-12-18       Impact factor: 9.306

6.  Neurological soft signs in schizophrenia: a meta-analysis.

Authors:  Raymond C K Chan; Ting Xu; R Walter Heinrichs; Yue Yu; Ya Wang
Journal:  Schizophr Bull       Date:  2009-04-17       Impact factor: 9.306

7.  Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations.

Authors:  Anwar Mechri; Marie-Chantal Bourdel; Héla Slama; David Gourion; Lotfi Gaha; Marie-Odile Krebs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

8.  Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology.

Authors:  Konasale M Prasad; Richard Sanders; John Sweeney; Debra Montrose; Vaibhav Diwadkar; Diana Dworakowski; Jean Miewald; Matcheri Keshavan
Journal:  Schizophr Res       Date:  2008-12-23       Impact factor: 4.939

9.  Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; David P Gavin; Alessandro Guidotti; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2013-06-28       Impact factor: 4.939

10.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.